Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.49 |
| ▸ | MAOA | P21397 | 4/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8990219 | 0.84 | ACHE (0.53) | ACHEMAOAMAOB | |
| SCHEMBL3742970 | 0.81 | ACHE (0.50) | ACHEMAOA | |
| SCHEMBL15931777 | 0.81 | ACHE (0.41) | ACHE | |
| SCHEMBL15931789 | 0.81 | ACHE (0.41) | ACHE | |
| SCHEMBL19313325 | 0.77 | ACHE (0.38) | ACHEMAOA | |
| SCHEMBL1454366 | 0.77 | ACHE (0.59) | ACHEMAOAMAOB | |
| SCHEMBL17135796 | 0.76 | ACHE (0.49) | ACHEMAOAMAOB | |
| SCHEMBL17147586 | 0.76 | ACHE (0.49) | ACHEMAOAMAOB | |
| SCHEMBL3688423 | 0.76 | ACHE (0.41) | ACHE | |
| SCHEMBL3685904 | 0.76 | ACHE (0.41) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569532-B2 | Catalysts | BOREALIS TECHNOLOGY OY (FI) | 2013-10-29 | — | — | US | disclosed |
| US-8569532-B2 | Catalysts | BOREALIS TECHNOLOGY OY (FI) | 2013-10-29 | — | — | US | disclosed |
| US-8569532-B2 | Catalysts | BOREALIS TECHNOLOGY OY (FI) | 2013-10-29 | — | — | US | disclosed |
| US-20120252993-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2012-10-04 | — | — | US | disclosed |
| US-20120252993-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2012-10-04 | — | — | US | disclosed |
| US-20120252993-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2012-10-04 | — | — | US | disclosed |
| US-20100305286-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2010-12-02 | — | — | US | disclosed |
| US-20100305286-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2010-12-02 | — | — | US | disclosed |
| US-20100305286-A1 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2010-12-02 | — | — | US | disclosed |
| EP-2215129-A2 | CATALYSTS | Borealis Technology OY (FI) | 2010-08-11 | — | — | EP | disclosed |
| WO-2009027075-A2 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009027075-A2 | CATALYSTS | BOREALIS TECHNOLOGY OY (FI) | 2009-03-05 | — | — | WO | disclosed |
| EP-1636245-B1 | BISINDENYL ZIRCONIUM COMPLEXES FOR USE IN THE POLYMERISATION OF OLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2009-02-25 | — | — | EP | disclosed |
| US-20060252637-A1 | Bisindenyl zirconium complexes for use in the polymerization of olefins | BASELL POLYOLEFINE GMBH (DE) | 2006-11-09 | — | — | US | disclosed |
| EP-1636245-A1 | BISINDENYL ZIRCONIUM COMPLEXES FOR USE IN THE POLYMERISATION OF OLEFINS | Basell Polyolefine GmbH (DE) | 2006-03-22 | — | — | EP | disclosed |
| WO-2004106351-A1 | BISINDENYL ZIRCONIUM COMPLEXES FOR USE IN THE POLYMERISATION OF OLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2004-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120252993-A1 | CATALYSTS | CYP4F11, COXFA4, CYP2F1 | ACHE 1896/4885MAOA 187/4885CYP1A2 52/4885 |
| US-20100305286-A1 | CATALYSTS | H1-2, CCNL2, H1-3 | ACHE 3963/4885MAOA 4132/4885CYP1A2 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.